Rate-controlled atrial fibrillation means the heart is still in AFib, but medications or other treatments are keeping the heart rate within a safe range, typically below 80 beats per minute at rest. Rather than trying to restore a normal rhythm, rate control accepts that the upper chambers of the heart will continue to quiver irregularly and focuses on preventing the lower chambers from beating too fast in response.
This is one of two main strategies for managing AFib. The other, called rhythm control, aims to restore and maintain a normal heartbeat. For many people, rate control works just as well and comes with fewer side effects.
How Rate Control Differs From Rhythm Control
In a normal heart, electrical signals travel in an orderly pattern from the upper chambers (atria) to the lower chambers (ventricles), producing a steady heartbeat. In AFib, the atria fire chaotic electrical signals, and the ventricles try to keep up, often beating too fast as a result. That rapid, irregular heartbeat is what causes symptoms like palpitations, shortness of breath, fatigue, and dizziness.
Rate control doesn’t fix the chaotic signals in the atria. Instead, it slows down how many of those signals reach the ventricles, keeping the overall heart rate from climbing too high. Rhythm control takes the opposite approach: it uses medications or procedures to stop the chaotic signals altogether and restore a normal, steady rhythm. Both strategies aim to reduce symptoms, but they take fundamentally different paths to get there.
A landmark clinical trial called AFFIRM, which compared the two strategies head to head, found no survival advantage for either approach. In fact, rhythm control was associated with slightly higher mortality in patients over 65 and those without heart failure, likely due to side effects from the antiarrhythmic drugs used. This finding is a major reason rate control became the default first-line strategy for many AFib patients, particularly older adults with manageable symptoms.
Target Heart Rate Goals
There are two schools of thought on how aggressively to control the heart rate. A strict strategy targets a resting heart rate below 80 beats per minute and below 110 during moderate exercise. A lenient strategy simply aims for a resting heart rate below 110 beats per minute.
A trial published in the New England Journal of Medicine randomly assigned 614 patients with permanent AFib to one strategy or the other. The results showed no meaningful difference in outcomes between the two groups. Because of this, many clinicians start with the lenient target of under 110 bpm at rest and only tighten the goal if symptoms persist. Pushing the heart rate lower requires higher medication doses, which increases the risk of side effects like fatigue and dangerously slow heart rates.
Medications Used for Rate Control
Three main classes of drugs slow the heart rate in AFib, each working through a slightly different mechanism.
- Beta blockers (metoprolol, atenolol, bisoprolol, and others) reduce the heart rate by blocking adrenaline’s effect on the heart. They are the most commonly prescribed rate control drugs and also help lower blood pressure.
- Calcium channel blockers (diltiazem, verapamil) slow the electrical signals traveling from the upper to the lower chambers. They also weaken the force of heart contractions slightly, which makes them a poor choice for people with heart failure but a good option for many others.
- Digoxin slows conduction between the upper and lower chambers through a different pathway. It’s often added when a beta blocker or calcium channel blocker alone isn’t enough, particularly in people who are less active, since it’s less effective at controlling heart rate during exercise.
Many patients end up on a combination of these drugs. Your doctor will typically start with one and adjust based on how well your heart rate responds and how you feel day to day.
How Doctors Check If It’s Working
A standard electrocardiogram (ECG) gives a snapshot of your heart rate at one moment, but AFib is unpredictable. Your heart rate might be well controlled sitting in the doctor’s office and spike during a walk to the mailbox. For a more complete picture, doctors often use a Holter monitor, a small wearable device that records your heart’s electrical activity continuously for 24 hours or longer.
The average ventricular rate over each 24-hour period is the standard measure of how well rate control is working. General consensus considers good control to be 60 to 80 bpm at rest and 90 to 115 bpm during moderate exercise, though as noted above, many patients do fine with a more lenient target.
When Medications Aren’t Enough
For a small number of patients, medications fail to bring the heart rate down to a comfortable level, or the side effects are intolerable. In these cases, a procedure called AV node ablation with pacemaker implantation becomes an option. The doctor uses radiofrequency energy to destroy the electrical connection between the upper and lower chambers, then implants a pacemaker to keep the ventricles beating at a normal, steady rate.
This “ablate and pace” approach does not eliminate the AFib itself. The atria still fibrillate. But by severing the electrical link, the ventricles are no longer at the mercy of those chaotic signals. Studies show the procedure improves quality of life, exercise tolerance, and heart function in patients whose symptoms didn’t respond to drugs. The tradeoff is permanent dependence on a pacemaker.
Stroke Risk Remains
One critical point that catches many people off guard: rate control does not reduce your stroke risk. AFib increases stroke risk because blood can pool and clot in the quivering atria. Since rate control doesn’t stop the atria from fibrillating, the clotting risk remains. You will still need a blood thinner if your overall risk profile calls for one, regardless of how well your heart rate is controlled.
Stroke prevention is actually the first priority in AFib management, ahead of rate or rhythm decisions. Your doctor will assess your individual risk factors (age, history of stroke, high blood pressure, diabetes, heart failure, and vascular disease) to determine whether you need anticoagulation therapy. Most people with AFib do.
Risks of Rate Control Treatment
Rate control medications are generally well tolerated, but they’re not risk-free. The most common concern is pushing the heart rate too low. This can cause symptoms like lightheadedness, severe fatigue, fainting, or confusion, particularly in older adults. In some cases, symptomatic slow heart rates (bradycardia) become severe enough to require a permanent pacemaker.
People with paroxysmal AFib, where episodes come and go, face a specific challenge. Rate control drugs stay active even when the heart flips back to a normal rhythm, which can cause the heart rate to drop too low during those normal periods. This is one reason why monitoring matters and why your treatment plan may need periodic adjustment as your AFib pattern evolves over time.